Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses
NCT04648813
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Allergic Asthma
Interventions
DRUG:
tiotropium bromide monohydrate (Spiriva Respimat)
DRUG:
matching placebo
Sponsor
University of Saskatchewan